Matches in Wikidata for { <http://www.wikidata.org/entity/Q92369391> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q92369391 description "article scientifique publié en 2020" @default.
- Q92369391 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q92369391 description "im Januar 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92369391 description "scientific article published on 02 January 2020" @default.
- Q92369391 description "wetenschappelijk artikel" @default.
- Q92369391 description "наукова стаття, опублікована 2 січня 2020" @default.
- Q92369391 description "գիտական հոդված հրատարակված 2020 թվականի հունվարի 2-ին" @default.
- Q92369391 name "Open-label Phase II trial to evaluate safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination for stage-IV non-small-cell lung cancer - VinMetAtezo trial, (GFPC‡ 04-2017)" @default.
- Q92369391 name "Open-label Phase II trial to evaluate safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination for stage-IV non-small-cell lung cancer - VinMetAtezo trial, (GFPC‡ 04-2017)" @default.
- Q92369391 type Item @default.
- Q92369391 label "Open-label Phase II trial to evaluate safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination for stage-IV non-small-cell lung cancer - VinMetAtezo trial, (GFPC‡ 04-2017)" @default.
- Q92369391 label "Open-label Phase II trial to evaluate safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination for stage-IV non-small-cell lung cancer - VinMetAtezo trial, (GFPC‡ 04-2017)" @default.
- Q92369391 prefLabel "Open-label Phase II trial to evaluate safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination for stage-IV non-small-cell lung cancer - VinMetAtezo trial, (GFPC‡ 04-2017)" @default.
- Q92369391 prefLabel "Open-label Phase II trial to evaluate safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination for stage-IV non-small-cell lung cancer - VinMetAtezo trial, (GFPC‡ 04-2017)" @default.
- Q92369391 P1433 Q92369391-54027A1D-6D5B-4969-8231-B13144D43970 @default.
- Q92369391 P1476 Q92369391-8687E46A-6C8B-4493-908F-DB02B7B195B5 @default.
- Q92369391 P2093 Q92369391-2CC79590-41A5-4B71-97C0-D39D0BF0AD04 @default.
- Q92369391 P2093 Q92369391-3E3889EA-156C-466B-9802-5060B0FA3D5D @default.
- Q92369391 P2093 Q92369391-5FD5EAAC-2E6D-4D10-869D-D7510E91DF46 @default.
- Q92369391 P2093 Q92369391-9BCECDCD-50DB-4228-8605-0DFE75701B93 @default.
- Q92369391 P2093 Q92369391-C0D732FD-CD8B-4BC4-9880-BC09AB9ABEFA @default.
- Q92369391 P2093 Q92369391-D4B65F63-F70F-4ACD-B9C0-DBE62CAA04E4 @default.
- Q92369391 P2093 Q92369391-D6D41ECF-B85B-41DC-A039-DFF36BCB4D10 @default.
- Q92369391 P304 Q92369391-473E6542-F52C-4214-8D3C-2EB46C411848 @default.
- Q92369391 P31 Q92369391-FC7EC530-A36A-459F-AFD1-F95D8768AA33 @default.
- Q92369391 P356 Q92369391-F0BB3B53-38CA-4188-88BB-09CAD40BC787 @default.
- Q92369391 P433 Q92369391-15B85707-288F-4CC2-AF09-C1F0454A27C1 @default.
- Q92369391 P478 Q92369391-4DD9BB4D-379C-4F82-AA54-A46203526DF2 @default.
- Q92369391 P50 Q92369391-A550482E-4D62-45B9-9830-20B90C417DE5 @default.
- Q92369391 P577 Q92369391-0A38A387-F5A4-4FC6-B76F-5577952CC686 @default.
- Q92369391 P698 Q92369391-902098AB-F5AD-4DE9-87A7-D7F84627023A @default.
- Q92369391 P921 Q92369391-30BD907E-86AA-4C26-867F-16FE28E34018 @default.
- Q92369391 P356 FON-2019-0730 @default.
- Q92369391 P698 31894704 @default.
- Q92369391 P1433 Q2781597 @default.
- Q92369391 P1476 "Open-label Phase II trial to evaluate safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination for stage-IV non-small-cell lung cancer - VinMetAtezo trial, (GFPC‡ 04-2017)" @default.
- Q92369391 P2093 "Acya Bizieux" @default.
- Q92369391 P2093 "Alain Vergnenegre" @default.
- Q92369391 P2093 "Anne Marie Chiapa" @default.
- Q92369391 P2093 "Gilles Robinet" @default.
- Q92369391 P2093 "Hervé Léna" @default.
- Q92369391 P2093 "Isabelle Monnet" @default.
- Q92369391 P2093 "Marie Bernardi" @default.
- Q92369391 P304 "5-10" @default.
- Q92369391 P31 Q13442814 @default.
- Q92369391 P356 "10.2217/FON-2019-0730" @default.
- Q92369391 P433 "4" @default.
- Q92369391 P478 "16" @default.
- Q92369391 P50 Q57027992 @default.
- Q92369391 P577 "2020-01-02T00:00:00Z" @default.
- Q92369391 P698 "31894704" @default.
- Q92369391 P921 Q42824440 @default.